Sinocare Inc.

SZSE:300298 Stock Report

Market Cap: CN¥13.0b

Sinocare Valuation

Is 300298 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 300298 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 300298 (CN¥23.43) is trading below our estimate of fair value (CN¥24.93)

Significantly Below Fair Value: 300298 is trading below fair value, but not by a significant amount.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 300298?

Key metric: As 300298 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 300298. This is calculated by dividing 300298's market cap by their current earnings.
What is 300298's PE Ratio?
PE Ratio58.5x
EarningsCN¥221.71m
Market CapCN¥12.98b

Price to Earnings Ratio vs Peers

How does 300298's PE Ratio compare to its peers?

The above table shows the PE ratio for 300298 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average77.9x
688301 iRay Technology
28.4x27.5%CN¥16.0b
688198 Beijing Balance Medical TechnologyLtd
155.9x41.1%CN¥16.1b
300633 SonoScape Medical
61.7x55.2%CN¥15.0b
600055 Beijing Wandong Medical TechnologyLtd
65.7xn/aCN¥12.1b
300298 Sinocare
58.5x34.9%CN¥13.0b

Price-To-Earnings vs Peers: 300298 is good value based on its Price-To-Earnings Ratio (58.5x) compared to the peer average (77.9x).

Price to Earnings Ratio vs Industry

How does 300298's PE Ratio compare vs other companies in the CN Medical Equipment Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
No more companies available in this PE range
300298 58.5xIndustry Avg. 35.0xNo. of Companies18PE020406080100+
0 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 300298 is expensive based on its Price-To-Earnings Ratio (58.5x) compared to the CN Medical Equipment industry average (34.5x).

Price to Earnings Ratio vs Fair Ratio

What is 300298's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

300298 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio58.5x
Fair PE Ratio35.6x

Price-To-Earnings vs Fair Ratio: 300298 is expensive based on its Price-To-Earnings Ratio (58.5x) compared to the estimated Fair Price-To-Earnings Ratio (35.6x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 300298 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentCN¥23.43
CN¥31.10
+32.7%
7.4%CN¥34.30CN¥29.00n/a3
Nov ’25CN¥25.71
CN¥31.10
+21.0%
7.4%CN¥34.30CN¥29.00n/a3
Oct ’25CN¥30.30
CN¥30.35
+0.2%
4.2%CN¥32.04CN¥29.00n/a3
Sep ’25CN¥24.51
CN¥30.35
+23.8%
4.2%CN¥32.04CN¥29.00n/a3
Aug ’25CN¥22.01
CN¥29.68
+34.8%
7.0%CN¥32.04CN¥27.00n/a3
Jul ’25CN¥25.00
CN¥29.52
+18.1%
8.5%CN¥32.04CN¥27.00n/a2
Jun ’25CN¥27.87
CN¥29.52
+5.9%
8.5%CN¥32.04CN¥27.00n/a2
May ’25CN¥23.89
CN¥31.01
+29.8%
9.5%CN¥34.00CN¥27.00n/a3
Apr ’25CN¥21.21
CN¥31.71
+49.5%
10.5%CN¥34.12CN¥27.00n/a3
Mar ’25CN¥22.90
CN¥33.93
+48.2%
0.5%CN¥34.12CN¥33.68n/a3
Feb ’25CN¥23.61
CN¥33.93
+43.7%
0.5%CN¥34.12CN¥33.68n/a3
Jan ’25CN¥30.40
CN¥33.93
+11.6%
0.5%CN¥34.12CN¥33.68n/a3
Dec ’24CN¥29.82
CN¥33.93
+13.8%
0.5%CN¥34.12CN¥33.68n/a3
Nov ’24CN¥29.76
CN¥34.06
+14.4%
0.2%CN¥34.12CN¥34.00CN¥25.712
Oct ’24CN¥25.66
CN¥33.71
+31.4%
0.9%CN¥34.00CN¥33.41CN¥30.302
Sep ’24CN¥24.28
CN¥36.71
+51.2%
9.0%CN¥40.00CN¥33.41CN¥24.512
Aug ’24CN¥24.26
CN¥39.90
+64.5%
0.3%CN¥40.00CN¥39.80CN¥22.012
Jul ’24CN¥27.04
CN¥39.90
+47.6%
0.3%CN¥40.00CN¥39.80CN¥25.002
Jun ’24CN¥29.68
CN¥39.90
+34.4%
0.3%CN¥40.00CN¥39.80CN¥27.872
May ’24CN¥28.74
CN¥39.90
+38.8%
0.3%CN¥40.00CN¥39.80CN¥23.892
Jan ’24CN¥33.73
CN¥35.67
+5.8%
10.3%CN¥39.34CN¥32.00CN¥30.402
Dec ’23CN¥33.29
CN¥35.67
+7.1%
10.3%CN¥39.34CN¥32.00CN¥29.822
Nov ’23CN¥36.36
CN¥35.67
-1.9%
10.3%CN¥39.34CN¥32.00CN¥29.762

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.

Discover undervalued companies

Shenzhen Lifotronic Technology

CN¥6.8b

Research, develops, manufactures, and markets medical devices for diagnostics, clinical medicine, skin, and human health related purposes in China.

688389

CN¥15.77

7D

-3.4%

1Y

-34.8%

Chison Medical Technologies

CN¥2.7b

Manufactures and sells diagnostic ultrasound systems in China and internationally.

688358

CN¥25.71

7D

3.4%

1Y

-42.1%

Innovita Biological Technology

CN¥5.7b

Engages in the research and development, manufacturing, marketing, and sales of POCT rapid diagnostic products.

688253

CN¥41.42

7D

1.5%

1Y

35.8%